SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFlowtech Fluid. Regulatory News (FLO)

Share Price Information for Flowtech Fluid. (FLO)

Share Price is delayed by 15 minutes
Get Live Data
54.60    -1.40 (-2.50%)
Bid:
52.60
Ask:
56.60
Spread: 4.00 (7.605%)
Market Cap: £45.60m
FLO Live PriceLast checked at - London Stock Exchange

Intraday Flowtech Fluid. Share Chart

FULL YEAR TRADING UPDATE

30 Jan 2025 07:00

RNS Number : 1954V
Flowtech Fluidpower PLC
30 January 2025
 

NEWS RELEASE

 

 

Issued on behalf of Flowtech Fluidpower plc

Immediate Release

Thursday 30 January 2025

 

\

 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014 as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

FLOWTECH FLUIDPOWER PLC

("Flowtech", the "Group" or "the Company")

 

Our aim is to provide our customers with power, motion & control solutions, from a single component to integrated engineering systems, in the most cost-effective way, harnessing the best global brands & products, services and engineers in the market.

 

FULL YEAR TRADING UPDATE

 

"Underlying EBITDA is broadly in line with expectations in a year focused on controlling the controllables in a difficult market. 

 

Strong progress has been made implementing our strategic plan with further operational improvements delivering enhancements to gross margins, working capital optimisation, service levels, and operational efficiencies. Group rebranding and restructuring are complete, and the successful integration of Thorite is well ahead of our expectations. With much of the business transformation concluded we have a firm, stable and scalable platform from which to deliver profitable growth into 2025 and beyond. 

 

We are well on track with the development of our new digital platform to be launched to market in H125 and there is confidence that the broader strategy and actions taken to improve operational efficiency within the business will drive strong returns and improved shareholder value."

Mike England, CEO

 

 

The Board of Flowtech issues the following unaudited Trading Update ahead of the Group's 2024 annual results.

2024 TRADING UPDATE

The Board is reporting that underlying EBITDA for the year ended 31 December 2024 is expected to be broadly in line with market expectations. We have also achieved a significant one-off profit , which will be separately disclosed, in relation to the Thorite acquisition due to having purchased assets below fair market value and therefore is not included in underlying EBITDA.

 

Segment revenue:

FY

2024

Unaudited

£m

FY

2023

Audited *

£m

Change

2024

v

2023

Great Britain excluding Thorite

71.5

77.4

-7.6%

Thorite***

4.7

-

N/A

Island of Ireland

21.0

24.1

-12.9%

Benelux

10.0

10.6

-5.5%

Total Group revenue for the period

107.3

112.1

-4.3%

Net debt**

15.1

14.7

0.4

 

Notes

* Approximately £2m of revenue has been reallocated from GB to Island of Ireland to better reflect the manner in which revenue streams are now being reported within the business

** Excludes IFRS16 related debt

*** 18-week period

 

Consensus forecasts FY24 prior to this announcement were: revenue £109m, underlying EBITDA £6.5m

and underlying operating profit £3.0m

 

The well-documented market headwinds persisted throughout the year, and as a result the Group experienced a revenue decline of 4.3%. The Thorite acquisition has been a great success: it is operating profitably, with the initial capital cost already repaid, and integration has exceeded expectations providing strong confidence in the stability and growth of this channel into 2025. Like for like revenue decline was 8.6% as customers reduced volumes, destocked, and delayed project timelines.

 

The British Fluid Power Association (BFPA) has consistently cited market decline of around 10% in Hydraulics and Pneumatics. As a result, we are pleased with our relative performance and confident that we have gained market share in an otherwise difficult year. Our sales pipeline and order book have continued to strengthen throughout the year, growing with a number of new exciting orders secured for execution in 2025.

 

Net debt** increased by £0.4m to £15.1m at year end (2023: £14.7m). As a board, we remain very focused on the management of working capital and are comfortable with the current debt profile of the business.

 

The team has worked tirelessly to improve the operational performance of the business, driving improved margins through commercial pricing and cost control, delivering enhanced service levels and on-time deliveries, strengthening the senior leadership team and optimising all aspects of the business. With the rebranding and restructuring now complete, and the new website launch expected in H1, we expect the improvements made across 2024 to bear fruit this year. We believe we have a strong, stable, and scalable platform for improved growth into 2025 and beyond.

 

 

ENQUIRIES:

Flowtech Fluidpower plc

Roger McDowell, Chair

Mike England, Chief Executive Officer

Russell Cash, Chief Financial Officer

Tel: +44 (0) 1695 52759

Email: info@flowtechfluidpower.com

 

Panmure Liberum (Nominated Adviser and Joint Broker)

Richard Lindley / Will King

Tel: +44 (0) 20 3100 2000

 

Singer Capital Markets (Joint broker)

Tom Salvesen, Head of Investment Banking

James Todd, Associate, Investment Banking

Tel: +44 (0) 207 496 3000

 

TooleyStreet Communications (IR and media relations)

Fiona Tooley

Tel: +44 (0) 7785 703523

or email: fiona@tooleystreet.com

 

 

EDITORS NOTE:

Flowtech Fluidpower plc (AIM:FLO), is the largest supplier of fluid power products, systems and solutions in the UK, Ireland, and Benelux. As a specialist we have the expertise and experience our customers need to help them minimise downtime, optimise performance and maximise the lifespan of operations. Today, the Company is a strong market leader in a highly fragmented £30bn European market. We work across virtually all industry sectors, serving the needs of our customers who are designing, building, maintaining, and improving industrial plant, equipment, and operations. To read more about the Group, please visit: www.flowtechfluidpower.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSEDESUEISEEF
Date   Source Headline
16th Apr 202012:48 pmRNSIssue of Equity and Total Voting Rights
2nd Apr 20207:00 amRNSBusiness Update - COVID-19;Notice of Final results
27th Mar 20202:46 pmRNSDirectorate Changes
6th Mar 202012:15 pmRNSHolding(s) in Company
17th Feb 20207:00 amRNSDirector/PDMR Shareholding
14th Feb 20203:12 pmRNSHolding(s) in Company
13th Feb 20203:58 pmRNSHolding(s) in Company
13th Feb 20207:00 amRNS2019 Trading update & restructuring activities
7th Feb 20204:44 pmRNSHolding(s) in Company
6th Feb 20206:07 pmRNSHolding(s) in Company
20th Jan 20204:13 pmRNSHolding(s) in Company
15th Jan 20204:38 pmRNSHolding(s) in Company
14th Jan 20207:00 amRNSTrading Update - for the year to 31 December 2019
17th Dec 20195:43 pmRNSHolding(s) in Company
5th Dec 20194:41 pmRNSSecond Price Monitoring Extn
5th Dec 20194:35 pmRNSPrice Monitoring Extension
2nd Dec 20194:40 pmRNSSecond Price Monitoring Extn
2nd Dec 20194:35 pmRNSPrice Monitoring Extension
27th Nov 20191:51 pmRNSDirector/PDMR Shareholding
25th Nov 20194:40 pmRNSSecond Price Monitoring Extn
25th Nov 20194:35 pmRNSPrice Monitoring Extension
22nd Nov 20194:40 pmRNSSecond Price Monitoring Extn
22nd Nov 20194:35 pmRNSPrice Monitoring Extension
30th Oct 20199:30 amRNSDirector Share Option Award
28th Oct 20197:00 amRNSDirector/PDMR Shareholding
22nd Oct 20197:00 amRNSTrading update -nine month period to 30 Sept 2019
30th Sep 20194:10 pmRNSCorrection: Director/PDMR Shareholding
30th Sep 201911:32 amRNSDirector/PDMR Shareholding
24th Sep 20197:00 amRNSHalf-Year Report - six months ended 30 June 2019
15th Aug 20191:56 pmRNSDirector/PDMR Shareholding
14th Aug 201912:08 pmRNSSecond Price Monitoring Extn
14th Aug 201912:02 pmRNSPrice Monitoring Extension
30th Jul 20197:00 amRNSIssue of Equity and Total Voting Rights (TVR)
18th Jul 201911:29 amRNSDirector/PDMR Shareholding
16th Jul 201912:07 pmRNSSecond Price Monitoring Extn
16th Jul 201912:02 pmRNSPrice Monitoring Extension
12th Jul 20197:00 amRNSGroup Trading Update & Notice of Half-Year results
13th Jun 201911:25 amRNSIssue of Equity and Total Voting Rights
5th Jun 201910:56 amRNSResults of Voting AGM - 5 June 2019 and TVR
5th Jun 20198:46 amRNS2019 Annual General Meeting Statement
16th May 20197:00 amRNSDeferred Consideration and Total Voting Rights
8th May 20191:35 pmRNSAudited Results - Notice of Annual General Meeting
7th May 201911:34 amRNSHolding(s) in Company
17th Apr 20195:21 pmRNSHolding(s) in Company
16th Apr 20197:00 amRNSPreliminary results - year ended 31 December 2018
16th Apr 20197:00 amRNSQ1 2019 Trading Update
8th Apr 20195:04 pmRNSHolding(s) in Company
26th Mar 20197:00 amRNSHolding(s) in Company
18th Mar 201911:29 amRNSDirector/PDMR Shareholding
19th Feb 20196:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.